Light Therapy for Dementia

After successfully completing initial safety and feasibility trials, Quietmind Foundation, in cooperation with Texas A&M and Baylor Scott & White Research Institute, enrolled 100 adults (50-85) with memory loss for a new innovative clinical study. This study recently completed and published click the link below to download the study findings.

1transcranial_near_infrared_light_stimulations_improve_cognition_in_patients_with_dementia.pdf
File Size:	470 kb
File Type:	pdf

Download File

About The Clinical Trial
In cooperation with Texas A&M University's Dept. of Neurosurgery, Quietmind Foundation enrolled individuals age 50-85 years experiencing memory problems and who had been independently diagnosed with early to mid-stage dementia to participate in this trial. The study used low-level infrared light stimulation directed to the head. The stimulation sessions were conducted at home, twice daily, for 5 minutes over 60 consecutive days. The trial was randomized, placebo controlled and double blinded.
Trial Procedure:
Individuals that matched the clinical trial eligibility criteria went through two unique assessments at the start, mid-point, and ending of the trial period.

First, subjects completed a Quantitative EEG assessment. This assessment involved wearing a cap with sensors that record the brain's electrical activity. This is a non-invasive procedure and completed in less than 30-minutes. This assessment is conducted in-person.
Subjects then completed a standardized memory assessment. This assessment takes an hour and was conducted remotely by the study neuropsychologist.

Following these first two assessments, participants received a light therapy device that they will wear for 5-minutes, twice daily for 2 months. This device uses safe LED lights that stimulate blood flow and reduce inflammation in the brain.

Participants repeated the EEG and cognitive assessments twice more during the two month trial.

Dr. Marvin Berman, PhD CBT is the founder of the Quietmind Foundation and leading the research trial.

This study has been completed and we are now offering ongoing treatment and consultation using either the Cognitolite or Neuradiant 1070 technology. These are described in detail in the 'Equipment' category.

Please complete the contact form and Dr. Berman will contact you to discuss the options for obtaining a transcranial light therapy device and related neurotherapy and functional medicine support that may be helpful for your situation.

* Indicates required field

Name *

First

Last

Email *

Phone Number *

Address *

Line 1

Line 2

City

State

Zip Code

Country

Are you or a loved one experiencing memory loss? *

Yes No

What is the age of the person with memory loss? *

Under 50 50-85 Over 85

Have you been diagnosed with some type of dementia? *

Yes No Not sure

Add any information you wish to share here. *

Submit Answers

Self-administered, safe, drug-free and effective approach to Improve Dementia Symptoms

Our mission is to study, provide and promote drug-free, low-cost, noninvasive approaches to understanding and treating disorders that affect people's thinking, behavior, and movement.

Office Hours

Locations

Telephone Number

Email

Support Us